These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2378793)

  • 1. Lack of effect of the specific cholecystokinin receptor antagonist loxiglumide on cholecystokinin clearance from plasma in man.
    Jebbink MC; Jansen JB; Masclee AA; Lamers CB
    Br J Clin Pharmacol; 1990 Jun; 29(6):770-3. PubMed ID: 2378793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin in man.
    Jansen JB; Jebbink MC; Douglas BR; Lamers CB
    Eur J Clin Pharmacol; 1990; 38(4):367-70. PubMed ID: 2344859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion.
    Schmidt WE; Creutzfeldt W; Höcker M; Nustede R; Choudhury AR; Schleser A; Rovati LC; Fölsch UR
    Eur J Clin Invest; 1991 Oct; 21(5):501-11. PubMed ID: 1752290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man.
    Konturek JW; Konturek SJ; Kurek A; Bogdal J; Oleksy J; Rovati L
    Gut; 1989 Aug; 30(8):1136-42. PubMed ID: 2767511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
    Gabryelewicz A; Kulesza E; Konturek SJ
    Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist.
    Baum F; Nauck MA; Ebert R; Cantor P; Hoffmann G; Choudhury AR; Schmidt WE; Creutzfeldt W
    Digestion; 1992; 53(3-4):189-99. PubMed ID: 1291406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
    Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR
    Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.
    Lieverse RJ; Jansen JB; Masclee AA; Rovati LC; Lamers CB
    Gut; 1994 Apr; 35(4):501-5. PubMed ID: 8174988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the specific cholecystokinin-receptor antagonist loxiglumide on bombesin stimulated pancreatic enzyme secretion in man.
    Jebbink MC; Jansen JB; Mooy DM; Rovati LC; Lamers CB
    Regul Pept; 1991 Feb; 32(3):361-8. PubMed ID: 1714084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide.
    Fried M; Erlacher U; Schwizer W; Löchner C; Koerfer J; Beglinger C; Jansen JB; Lamers CB; Harder F; Bischof-Delaloye A
    Gastroenterology; 1991 Aug; 101(2):503-11. PubMed ID: 2065926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
    Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
    Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C
    J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of somatostatin and loxiglumide on gallbladder motility.
    Lieverse RJ; Jansen JB; Jebbink MC; Masclee AA; Rovati LC; Lamers CB
    Eur J Clin Pharmacol; 1995; 47(6):489-92. PubMed ID: 7768249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
    Hildebrand P; Beglinger C; Gyr K; Jansen JB; Rovati LC; Zuercher M; Lamers CB; Setnikar I; Stalder GA
    J Clin Invest; 1990 Mar; 85(3):640-6. PubMed ID: 2312719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cholecystokinin receptor antagonist CR1409 increases plasma cholecystokinin in rats.
    Jansen JB; de Jong AJ; Lamers CB
    Regul Pept; 1989 Feb; 24(2):209-13. PubMed ID: 2922496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of CCK receptor blockade on intestinal motor activity in conscious dogs.
    Niederau C; Karaus M
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G315-24. PubMed ID: 1996649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of plasma cholecystokinin (CCK) concentrations by bioassay and radioimmunoassay in man. A critical evaluation.
    Höcker M; Schmidt WE; Creutzfeldt W; Choudhury AR; Nustede R; Schafmayer A; Fölsch UR
    Regul Pept; 1992 Feb; 37(3):255-69. PubMed ID: 1557514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without affecting gastric emptying.
    Corazziari E; Ricci R; Biliotti D; Bontempo I; De Medici A; Pallotta N; Torsoli A
    Dig Dis Sci; 1990 Jan; 35(1):50-4. PubMed ID: 2295294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW
    J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.